Disclosure 0001193125-26-356853-1

SEC FORM 4

$680,291.28

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Sale of 18,600 shares at $36.5748 per share.

Reporting Person Lippman Evan · Officer Title EVP, Business Development · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001193125-26-356853 · filed 2026-08-19 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)." Disclosed 2026-08-19. https://desqlong.com/cards/0001193125-26-356853-1 (retrieved 2026-09-26).